BJDX
$2.02+0.07 (+3.59%)
Market ClosedAs of Mar 20, 8:00 PM UTC
Bluejay Diagnostics, Inc.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$2.02
Potential Upside
5%
Whystock Fair Value$2.12
Price
UndervaluedFair ValueOvervalued
Fundamentals
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay prepa...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.96M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.72
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-185.51%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.92
Recent News
Traders Digest Earnings, Powell Speech, Driving Muted Premarket Action for US Equity Futures
US equity futures were flat ahead of Thursday's opening bell as traders digested earnings from Pepsi
BC-Most Active Stocks
Gibo Holdings Ltd. 239,477,124 0.049